Acadia Pharma Announces License Agreement With Saniona For SAN711
27/11 04:26
(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) said that it has reached an exclusive worldwide license agreement with Saniona for the development and commercialization of SAN711, a first-in-class, highly selective GABAA-a3 positive allosteric modulator....